Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer’s Disease Progression

Cited by (605)

Items 601–605 of 605

  1. Collagen Triple Helix Repeat Containing 1 (CTHRC1) in the Nervous System: Expression, Signaling Mechanisms, and Functional Implications
    Yingying Lei, Yuxi Luo, Ling Li · 2026 · Journal of Molecular Neuroscience
  2. Region-specific proteomic analysis of aging rhesus macaques following chronic glutamate-carboxypeptidase-II (GCPII) inhibition elucidates potential treatment strategies for sporadic Alzheimer’s disease
    Alexandra D. Steigmeyer, Alexandria S. Battison, Iris R. Liebman, Christopher H. van Dyck, Barbara Stauch Slusher, Amy F.T. Arnsten, Stacy Alyse Malaker, Dibyadeep Datta · 2026 · Acta Neuropathologica Communications
  3. H3K9me3 inhibition reverses Alzheimer's progression by restoring synaptic and immune proteostasis across the brain–retina axis
    D. Fuchs, Jean-Philippe Vit, A. Rentsendorj, Yosef Koronyo, J. Sheyn, B. Gaire, Saba Shahin, Hao-Shen Shi, O. Chepurna, M. R. Davis et al. · 2026 · Alzheimer's & Dementia
  4. Suppression of Tau-tubulin kinase 1 mitigates tau phosphorylation, and Aβ mediated neurotoxicity via altered kinase network
    Kayo Yukawa, Satoshi Muraoka, Samtani Grace, Louis Cafaro, Jun Adachi, Tsuneya Ikezu, Seiko Ikezu · 2026 · Molecular & Cellular Proteomics
  5. Xanthohumol promotes cognitive function-associated neuroprotein changes in two mouse models of Alzheimer’s disease
    Wei Liu, Benhong Xu, 任晓虎, Chen Yang, Guowei Li, Zhen Zhang, Xifei Yang, Jianjun Liu · 2026 · IBRO Neuroscience Reports